Bristol Myers Squibb

Bristol Myers Squibb

featured image of BMS to Build $400M Biologics Facility in Dublin Boosting Manufacturing Capacity
Companies

BMS to Build $400M Biologics Facility in Dublin Boosting Manufacturing Capacity

BIOT

📢 Bristol Myers Squibb (BMS) invests $400M in a new sterile drug product facility in Dublin, Ireland. 🌍💪🧪🔬 Expected completion: 2026.

featured image of BMS Expands Oncology Portfolio with $41bn RayzeBio Acquisition
Companies

BMS Expands Oncology Portfolio with $41bn RayzeBio Acquisition

BIOT

💼 Bristol Myers Squibb (BMS) acquires RayzeBio for $4.1bn, expanding its oncology portfolio with targeted radiopharmaceuticals. ⚕️🎯

featured image of Revolutionary Modeling Boosts Efficiency of rAAV Therapies
Process development

Revolutionary Modeling Boosts Efficiency of rAAV Therapies

BIOT

🔬 Scientists from Bristol Myers Squibb and Lund University developed a mechanistic modeling approach for optimizing rAAV therapies. 🧪

Bioprocessupdates

©2023 - 2026 BioprocessUpdates

PRIVACY POLICY terms of service contact